Jacob A Frenkel Brainstorm Cell Therapeutics Inc. (BCLI) insider trading activity

BCLI Quotes by TradingView

Jacob A Frenkel is Director of BRAINSTORM CELL THERAPEUTICS INC.. Currently has a direct ownership of 43,777 shares of BCLI, which is worth approximately $97,622. The most recent transaction as insider was on Jan 01, 2025, when has been sold 40,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.8K
n/a 3M change
n/a 12M change
Total Value Held $97,622

JACOB A FRENKEL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 01 2025
BUY
Grant, award, or other acquisition
-
40,000 Added 47.75%
43,777 Common Stock

Also insider at

L
LOEWS CORP Financial Services
Director
JAF

Jacob A Frenkel

Director
New York, NY

Track Institutional and Insider Activities on BCLI

Follow BRAINSTORM CELL THERAPEUTICS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCLI shares.

Notify only if

Insider Trading

Get notified when an Brainstorm Cell Therapeutics Inc. insider buys or sells BCLI shares.

Notify only if

News

Receive news related to BRAINSTORM CELL THERAPEUTICS INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BCLI